Researchers at Jianghan University in Wuhan, China, have synthesized and characterized two novel palladium(ii) complexes with SNS-donor ligands, showing promising antiproliferative activity against various cancer cell lines, including colon, liver, and breast cancer. These complexes demonstrated higher efficacy and lower toxicity compared to cisplatin, making them potential candidates for colorectal cancer treatment. The study also highlighted the complexes' interactions with DNA, as well as their ability to induce cell apoptosis and mitochondrial-membrane depolarization in cancer cells. This research, published in Dalton Transactions, provides valuable insights into the development of new anticancer agents. [Extracted from the article]